THERIVA BIOLOGICS INC (TOVX) Stock Balance Sheet
NYSEARCA:TOVX - NYSE Arca - US87164U5083 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 10.01M | 11.61M | 23.18M | 41.79M | 67.33M | |||
| Receivables | 1.70M | 3.32M | 1.94M | 230.00K | 0.00 | |||
| Other Current Assets | 766.00K | 1.35M | 2.29M | 3.50M | 1.53M | |||
| Total Current Assets | 12.48M | 16.28M | 27.40M | 45.52M | 68.86M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.42M | 1.54M | 21.94M | 20.69M | 1.48M | |||
| Goodwill | N/A | 0.00 | 5.70M | 5.53M | N/A | |||
| Intangibles | 18.08M | 17.36M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 177.00K | 171.00K | 180.00K | 120.00K | 20.00K | |||
| Total Non-Current Assets | 19.68M | 19.07M | 27.82M | 26.34M | 1.51M | |||
| TOTAL ASSETS | 32.16M | 35.35M | 55.22M | 71.86M | 70.37M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 51.00K | 61.00K | 63.00K | 60.00K | N/A | |||
| Accrued Expenses | 4.89M | 5.05M | 5.00M | 3.12M | 3.03M | |||
| Accounts Payable | 437.00K | 859.00K | 770.00K | 920.00K | 520.00K | |||
| Other Current Liabilities | 2.77M | 1.61M | 906.00K | 2.97M | N/A | |||
| Total Current Liabilities | 8.15M | 7.58M | 6.74M | 7.06M | 3.55M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.50M | 92.00K | 162.00K | 220.00K | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 0.00 | 1.62M | N/A | |||
| Other Non-Current Liabilities | 7.01M | 8.61M | 8.62M | 8.40M | 1.40M | |||
| Total Non-Current Liabilities | 8.52M | 8.70M | 8.78M | 10.24M | 1.41M | |||
| TOTAL LIABILITIES | 16.66M | 16.29M | 15.52M | 17.30M | 4.96M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -339.30M | -334.97M | -309.32M | -290.97M | -271.28M | |||
| Additional Paid In Capital | 355.60M | 355.50M | 346.52M | 343.75M | 336.56M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 3.00K | 3.00K | 2.75M | 2.75M | 130.00K | |||
| Treasury Stock | -288.00K | -288.00K | -288.00K | -290.00K | N/A | |||
| Other Shareholders' Equity | -524.00K | -1.18M | 32.00K | -680.00K | N/A | |||
| Shares Outstanding | 2.78M | 2.78M | 17.15M | 15.12M | 13.20M | |||
| Tangible Book Value per Share | -0.93 | 0.61 | 1.82 | 3.06 | 4.96 | |||
| Total Shareholders' Equity | 15.50M | 19.07M | 39.70M | 54.56M | 65.41M | |||
| TOTAL LIABILITIES AND EQUITY | 32.16M | 35.35M | 55.22M | 71.86M | 70.37M | |||
| Statistics | ||||||||
| Debt/Equity | 0.10 | 0.00 | 0.00 | 0.00 | N/A | |||
| Current Ratio | 1.53 | 2.15 | 4.07 | 6.45 | 19.40 | |||
| Return On Assets (ROA) | -77.15% | -72.56% | -33.23% | -27.87% | -32.95% | |||
| Return On Equity (ROE) | -160.11% | -134.54% | -46.22% | -36.71% | -35.45% | |||
All data in USD , ROIC based on taxRate of 0.21